Product Program year 2020 Source: CMS Open Payments

Diagnostics Information Systems

Device Molecular Diagnostics

Open in the dashboard

General payments

$652,616

172 payments

Research payments

$0

0 payments

Through program year 2020, $652,616 in general payments and $0 in research payments were reported against Diagnostics Information Systems (Molecular Diagnostics).

No combined total These are different kinds of money, reported under different rules. A meal and a clinical trial grant do not add up to anything meaningful, so this site does not add them.

By program year

2 rows
Year Kind Amount Payments
2020 General $569,398 75
2019 General $83,218 97

Breakdown

Who paid General payments · program years 2019–2020
  1. Roche Molecular Systems, Inc. $652,616 172 payments
Top recipients General payments · program year 2020
  1. David Schlossman Hematology & Oncology · Columbia, MO $491,002 86% · 19 payments
  2. Laurence Heifetz Medical Oncology · Truckee, CA $15,350 3% · 9 payments
  3. Kristin Rojas Surgical Oncology · Miami, FL $14,400 3% · 7 payments
  4. Alexandria Phan Medical Oncology · Milwaukee, WI $9,000 2% · 4 payments
  5. Thomas Boyd Hematology & Oncology · Spokane, WA $6,400 1% · 4 payments

The top 5 of 19 recipients; each share is of general payments naming this product in 2020.

The top 25 recipients, free in the app

Specialties paid General payments · program year 2020
  1. Hematology & Oncology Internal Medicine $506,559 89% · 8 practitioners
  2. Medical Oncology Internal Medicine $28,850 5% · 3 practitioners
  3. Surgical Oncology Surgery $19,440 3% · 2 practitioners
  4. Radiation Oncology Radiology $4,000 <1% · 1 practitioner
  5. Gynecologic Oncology Obstetrics & Gynecology $3,500 <1% · 1 practitioner

The top 5 of 9 specialties; each share is of general payments naming this product to practitioners with a specialty in 2020. Each practitioner is counted under their primary specialty.

The top 25 specialties, free in the app

Where the money went General payments · program year 2020
  1. Missouri $493,402 87% · 2 recipients
  2. California $19,716 3% · 6 recipients
  3. New York $14,400 3% · 1 recipient
  4. Texas $13,000 2% · 2 recipients
  5. Washington $6,400 1% · 1 recipient

The top 5 of 11 states; each share is of general payments naming this product in 2020 where a state was reported.

The top 25 states, free in the app

172 general

Every payment, record by record

Date, amount, who was paid and what for — filter by year and kind, or download as CSV, free, in files of 5,000 rows.

What you are looking at

Manufacturers name the drug, biological or device a payment relates to. CMS does not give products their own identifiers, so a product here is assembled from how it was reported — a brand may appear under more than one spelling, and this page covers one of them rather than the brand as a whole.

Provenance

Source: CMS Open Payments · through program year 2020

We reproduce what manufacturers reported. We do not verify, edit or correct the underlying records.

A payment record is not evidence of wrongdoing. Financial relationships between industry and medicine are legal, common and often necessary for research. Who Paid My Doc reports what was disclosed; it does not judge it.

Who Paid My Doc is independent and is not affiliated with, endorsed by or sponsored by CMS or any U.S. government agency. It is not a consumer reporting agency and this is not a consumer report; do not use it for decisions covered by the Fair Credit Reporting Act.

How to dispute or correct a record